AcouSort's rights issue fully subscribed

AcouSort AB (publ) ("AcouSort" or the “Company") announces today the final outcome of the rights issue of units with pre-emption rights for the Company’s shareholders, consisting of shares and series TO 2 warrants, which concluded on November 30, 2023 (the “Rights Issue"). The Rights Issue has been subscribed to a total of 100.0 percent, of which approximately 70.8 percent was subscribed with the support of subscription rights and approximately 29.2 percent was subscribed without the support of subscription rights. Through the Rights Issue, AcouSort is thus receiving approximately SEK 24.8 million before transaction costs. In the event of full exercise of all series TO 2 warrants ("Warrants") within the issued units, the Company may receive an additional approximately SEK 11.6 million.

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, United kingdom, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION WHERE SUCH ACTION IS WHOLLY OR PARTIALLY SUBJECT TO LEGAL RESTRICTIONS. SEE ALSO THE "IMPORTANT INFORMATION" SECTION BELOW.

The subscription period for the Rights Issue expired on November 30, 2023, and the compilation shows that 390,825 units, equivalent to approximately 70.8 percent of the Rights Issue, were subscribed with the support of subscription rights. Additionally, another 161,173 units were subscribed without the support of subscription rights, equivalent to approximately 29.2 percent of the Rights Issue. Therefore, no underwriting guarantees were utilized. The Rights Issue is fully subscribed to 100.0 percent, and AcouSort is thereby receiving approximately SEK 24.8 million before transaction costs.

Notification of allocation of units subscribed without the support of unit rights will be sent shortly to those who have been allocated units through a settlement note. The subscribed and allocated units must be paid in cash according to the instructions on the settlement note. Shareholders registered with a nominee will be notified of their allocation in accordance with the nominee's procedures. Allocation of units subscribed without the support of unit rights has been carried out in accordance with the principles set out in the information memorandum published by the Company on 14 November 2023. Each unit consists of three (3) shares and one (1) Warrant.

"As CEO, I am overwhelmed by the support we have received from our existing shareholders and warmly welcome new shareholders. Through the fully subscribed rights issue, we can continue to strengthen our commercial capacity and expand our presence in North America, Europe, and selected Asian markets. Thank you for your continued support," comments CEO Torsten Freltoft.

NUMBER OF SHARES AND SHARE CAPITAL

Through the Rights Issue, the share capital in the Company increases by SEK 165,599.40, from SEK 1,324,796.40 to SEK 1,490,395.80, and the number of shares increases by 1,655,994 shares, from 13,247,964 shares to 14,903,958 shares, corresponding to a dilution effect of approximately 11.1 percent. Upon full exercise of all issued Warrants, the share capital will increase by an additional SEK 55,199.80 and the number of shares by an additional 551,998 shares, corresponding to a dilution effect of approximately 3.6 percent.

TRADING IN BTU

Trading in paid subscribed units (BTU) is currently conducted on Nasdaq First North Growth Market under the ticker ACOU BTU until when the Rights Issue has been registered with the Swedish Companies Registration Office, which is expected to take place around week 50, 2023. Thereafter, after approximately one week, BTU will be converted into shares and Warrants and admitted to trading on Nasdaq First North Growth Market.

UNDERWRITING COMMITMENTS

Compensation for underwriting commitments amounts to eleven (11) percent of the underwriting amount in cash compensation.

WARRANTS
One (1) Warrant entitle the holder to subscribe for one (1) new share in the Company during the period from and including 10 March 2025 up to and including 24 March 2025, at a subscription price of SEK 21 per share. Upon full exercise of all issued Warrants, the Company may additionally receive at most MSEK 11.6 before transaction costs.

ADVISORS
Penser By Carnegie, Carnegie Investment Bank AB (publ) is the financial advisor and Fredersen Advokatbyrå AB is legal advisor to AcouSort in connection with the Rights Issue. Erik Penser Bank AB is the issuing agent.

FOR FURTHER INFORATION, PLEASE CONTACT:

Torsten Freltoft, VD
AcouSort AB
Telephone: +45 2045 0854
E-mail: torsten.freltoft@acousort.com

ABOUT ACOUSORT AB

AcouSort AB (corporate registration number 556824-1037) is an innovative technology company focusing on developing products and solutions for integrated preparation of biological samples. With the help of sound waves, the company's products can separate blood cells, concentrate, purify, and stain cells, exosomes, and bacteria from biological samples. The technology of the company's products is acoustofluidics, where sound waves and microfluidics enable automated handling of samples in a range of application areas, from research on new biomarkers to the development of new diagnostic systems for near-patient testing – so-called Point-of Care (POC) systems. The company's commercialization strategy is based on the already proven business model of providing separation modules to diagnostic system manufacturers for integrated sample preparation as well as to continue the commercialization of the company's research instruments. With the help of the company's products and development of point-of-care tests, new diagnostic systems and treatments are enabled, addressing some of the most challenging disease areas of our time: cancer, infectious diseases, and cardiovascular diseases. AcouSort is listed at Nasdaq First North Growth Market. The company’s Certified Adviser is Erik Penser Bank.

IMPORTANT INFORATION

The information in this press release does not constitute an offer to acquire, subscribe or otherwise trade in units, unit rights or other securities in AcouSort. The invitation to concerned persons to subscribe for units in AcouSort has only been made through the information memorandum published by AcouSort on 14 November 2023. No action has been taken, or will be taken, by AcouSort to permit an offer to the public in jurisdictions other than Sweden.

This press release may not be published or distributed, directly or indirectly, in or to Australia, Belarus, Hong Kong, Japan, Canada, New Zealand, Russia, Switzerland, Singapore, South Africa, United Kingdom, the United States or any other jurisdiction where such action in whole or in part is subject to legal restrictions, or would require additional prospectus, registration or other measures than what follows from Swedish law. The information in this press release may also not be forwarded or reproduced in a way that is contrary to such restrictions or would entail such requirements. Actions contrary to this instruction may constitute a violation of applicable securities legislation. No securities mentioned in this press release have been registered or will be registered under the United States Securities Act of 1933 as amended (the "Securities Act") and may not be offered, subscribed for, exercised, pledged, sold, resold, delivered or transferred, directly or indirectly, in or to the United States, except pursuant to an applicable exemption from the registration requirements of the Securities Act. The offer is also not directed at persons domiciled in Australia, Belarus, Hong Kong, Japan, Canada, New Zealand, Russia, Switzerland, Singapore, South Africa, United Kingdom or in any other jurisdiction where participation would require additional prospectus, registration or other measures than those that follow from Swedish law.

FORWARD-LOOKING STATEMENTS

This press release contains certain forward-looking statements that reflect AcouSorts’ current views and expectations regarding future events and financial and operational developments, including statements regarding the Rights Issue and statements regarding guidance, planning, prospects and strategies. Words such as "intended," "estimated," "expected," "planned," "estimated," "may," and other expressions that imply indications or predictions of future developments or trends and are not based on historical facts constitute forward-looking statements information. Although AcouSort believes that these statements are based on reasonable assumptions and expectations, AcouSort cannot guarantee that such forward-looking statements will be realized. Because these forward-looking statements involve both known and unknown risks and uncertainties, actual outcomes may differ materially from those expressed in forward-looking information. Forward-looking statements in the press release speak only as of the date of the press release and are subject to change without notice. Potential investors should not place undue reliance on the forward-looking information contained herein, and potential investors are strongly encouraged to read those parts of the prospectus that include a more detailed description of factors that may affect the Company's business and the market in which the Company operates. The Company makes no promises to publish updates or revisions to forward-looking statements as a result of new information, future events or the like beyond what is required by applicable laws or stock market regulation.